US 10166216
Substituted triazoles useful as Axl inhibitors
granted A61KA61K31/4196A61K31/428
Quick answer
US patent 10166216 (Substituted triazoles useful as Axl inhibitors) held by Rigel Pharmaceuticals, Inc. expires Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Jan 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K31/4196, A61K31/428, A61K31/4355, A61K31/4439